Wyeth

Wyeth is among the world’s largest Pharmaceuticals sector businesses in the world. Wyeth’s employees generate $4.331B in profits on $20.881B of revenue. Global output in the Pharmaceuticals business will likely rise substantially over the next 10 years. Long-term economic growth may lift all boats, but Wyeth is determined to remain a market leader. Sectoral leadership in the Pharmaceuticals segment takes dedication and consistency, but management seeks out-sized growth.

Wyeth’s ticker symbol WYE has recently been trading near $57.68 a share. The Wyeth corporate headquarters in Madison NJ predicts Pharmaceuticals profits will satisfy shareholders in search of risk-appropriate returns.

The significance of market volume is sometimes ignored, but with a total market capitalization of $77.589B ensures sufficient liquidity. With a beta of 0.51, the company is less volatile than the market as a whole. When the average equity moves lower, Wyeth moves less aggressively.